Strata Critical Medical (SRTA) Non-Current Deffered Revenue (2019 - 2021)

Strata Critical Medical (SRTA) has reported Non-Current Deffered Revenue for 3 consecutive years, with $9.6 million the latest figure, recorded in Q1 2021.

• In Q1 2021, Non-Current Deffered Revenue changed 0.0% year-over-year to $9.6 million; the TTM figure through Mar 2021 stood at $9.6 million (changed 0.0% YoY), while the FY2020 annual figure was $9.6 million, changed N/A from the prior year.
• Non-Current Deffered Revenue steadied at $9.6 million in Q1 2021 per SRTA's latest filing, from $9.6 million in the prior quarter.
• Across five years, Non-Current Deffered Revenue topped out at $9.6 million in Q3 2019 and bottomed at $9.6 million in Q3 2019.
• Historically, Non-Current Deffered Revenue has averaged $9.6 million across 3 years, with a median of $9.6 million in 2019.
• On a YoY basis, Non-Current Deffered Revenue climbed as much as 0.0% in 2020 and fell as far as 0.0% in 2020.
• Strata Critical Medical's Non-Current Deffered Revenue stood at $9.6 million in 2019, then changed by 0.0% to $9.6 million in 2020, then changed by 0.0% to $9.6 million in 2021.
• Business Quant data shows SRTA's Non-Current Deffered Revenue at $9.6 million in Q1 2021, $9.6 million in Q4 2020, and $9.6 million in Q3 2020.